Introgen Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Introgen therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Introgen Therapeutics Today - Breaking & Trending Today

Recro Announces Executive Changes

Recro Announces Executive Changes
David Enloe Named President and Chief Executive Officer
December 16, 2020 07:00 ET
| Source:
Recro Pharma, Inc.
Recro Pharma, Inc.
Malvern, Pennsylvania, UNITED STATES
MALVERN, Pa., Dec. 16, 2020 (GLOBE NEWSWIRE) Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, today announced that David Enloe has been named President, Chief Executive Officer and a member of the Company’s Board of Directors, replacing Gerri Henwood, effective today.
Mr. Enloe brings over two decades of executive leadership experience in biotechnology, clinical drug development and GMP manufacturing to Recro, with a proven track record of building and growing CD ....

United States , San Diego , Bryan Lake , David Enloe , David Rosen , Sam Martin Claudia Styslinger , Wayneb Weisman , Gerri Henwood , Bachelor Of Business Administration , Company Board Of Directors , Baudax Bio Inc , Arthur Andersen Co , Exchange Commission , Recro Pharma Inc , University Of Texas At Austin , Securities Exchange , Ajinomoto Bio Pharma Services , Chief Executive Officer , Aji Bio Pharma , Baudax Bio , San Diego Business , Viral Therapeutics Business Unit , Preceding Vivante , Introgen Therapeutics , Senior Vice President , Business Administration ,

BioSpace Movers & Shakers, Dec. 18

Published: Dec 18, 2020
By Alex Keown
Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice president, for drug device industrialization at AbbVie, where he led product scale-up and industrialization projects for drug-device combinations. Prior to that, Kurtz held a number of leadership positions at various companies, including Monsanto, Nektar Therapeutics, Alza Corporation, Alexza and Novo Nordisk. ....

New York , United States , Rockefeller University , United Kingdom , Terri Gaskell , Peter Greenleaf , Scott Burger , Andrea Heslin Smiley , Eli Lilly , Jeffrey Vacira , Manny Triggiano , Dmitri Daveynis , Michael Weinblatt , N Manisha Shetty Gulati , Mervyn Turner , Sandip Kapadia , D Martin Carter , Djordje Filipovic , Perry Calias , Siemens Healthineers , Marylyn Rigby , Daphne Karydas , Badreddin Edris , David Enloe , Jeff Myers , Stanley Cohen ,

Recro Announces Executive ChangesDavid Enloe Named President and Chief Executive Officer

Published: Dec 16, 2020
MALVERN, Pa., Dec. 16, 2020 (GLOBE NEWSWIRE) Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, today announced that David Enloe has been named President, Chief Executive Officer and a member of the Company’s Board of Directors, replacing Gerri Henwood, effective today.
Mr. Enloe brings over two decades of executive leadership experience in biotechnology, clinical drug development and GMP manufacturing to Recro, with a proven track record of building and growing CDMO businesses. Most recently, he served as President and Chief Executive Officer of Ajinomoto Bio-Pharma Services, a global, fully integrated CDMO. Under Mr. Enloe’s leadership, Aji Bio-Pharma’s revenues have increased over 50% in a four-year period and h ....

United States , San Diego , Bryan Lake , David Enloe , David Rosen , Sam Martin Claudia Styslinger , Wayneb Weisman , Gerri Henwood , Bachelor Of Business Administration , Company Board Of Directors , Baudax Bio Inc , Arthur Andersen Co , Exchange Commission , University Of Texas At Austin , Securities Exchange , Ajinomoto Bio Pharma Services , Chief Executive Officer , Aji Bio Pharma , Baudax Bio , San Diego Business , Viral Therapeutics Business Unit , Preceding Vivante , Introgen Therapeutics , Senior Vice President , Business Administration , Certified Public Accountant ,